Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Prolonged Xenograft Survival Induced by Inducible Costimulator-Ig is Associated With Increased Forkhead Box P3+ Cells

dc.contributor.authorHodgson, Russell
dc.contributor.authorChristiansen, Dale
dc.contributor.authorZiolkowski, Andrew
dc.contributor.authorMouhtouris, Effie
dc.contributor.authorSimeonovic, Charmaine
dc.contributor.authorIerino, Francesco
dc.contributor.authorSandrin, Mauro
dc.date.accessioned2015-12-10T23:32:44Z
dc.date.issued2011
dc.date.updated2016-02-24T08:19:01Z
dc.description.abstractBackground: Blockade of the inducible costimulator (ICOS) pathway has been shown to prolong allograft survival; however, its utility in xenotransplantation is unknown. We hypothesize that local expression of ICOS-Ig by the xenograft will suppress the T-cell response resulting in significant prolonged graft survival. METHODS.: Pig iliac artery endothelial cells (PIEC) secreting ICOS-Ig were generated and examined for the following: (1) inhibition of allogeneic and xenogeneic proliferation of primed T cells in vitro and (2) prolongation of xenograft survival in vivo. Grafts were examined for Tregs by flow cytometry and cytokine levels determined by quantitative reverse-transcriptase polymerase chain reaction. Results: Soluble ICOS-Ig markedly decreased allogeneic and xenogeneic primed T-cell proliferation in a dose-dependent manner. PIEC-ICOS-Ig grafts were significantly prolonged compared with wild-type grafts (median survival, 34 and 12 days, respectively) with 20% of PIEC-ICOS-Ig grafts surviving more than 170 days. Histological examination showed a perigraft cellular accumulation of Forkhead box P3 (Foxp3) cells in the PIEC-ICOS-Ig grafts, these were also shown to be CD3+CD4+CD25+. Survival of wild-type PIEC grafts in a recipient simultaneously transplanted with PIEC-ICOS-Ig were also prolonged, with a similar accumulation of Foxp3 cells at the periphery of the graft demonstrating ICOS-Ig induces systemic graft prolongation. However, this prolongation was specific for the priming xenograft. Intragraft cytokine analysis showed an increase in interleukin-10 levels, suggesting a potential role in induction/function of CD4+CD25+Foxp3+ cells. Conclusions: This study demonstrates prolonged xenograft survival by local expression of ICOS-Ig, we propose that the accumulation of CD4+CD25+Foxp3+ cells at the periphery of the graft and secretion of interleukin-10 is responsible for this novel observation.
dc.identifier.issn0041-1337
dc.identifier.urihttp://hdl.handle.net/1885/68968
dc.publisherLippincott Williams & Wilkins
dc.sourceTransplantation
dc.subjectKeywords: CD28 antigen; complementary DNA; cytotoxic T lymphocyte antigen 4; immunoglobulin; immunoglobulin Fc fragment; inducible costimulator; interleukin 10; transcription factor FOXP3; unclassified drug; animal cell; animal experiment; animal model; article; CD Foxp3; ICOS-Ig; Treg; Xenotransplantation
dc.titleProlonged Xenograft Survival Induced by Inducible Costimulator-Ig is Associated With Increased Forkhead Box P3+ Cells
dc.typeJournal article
local.bibliographicCitation.issue10
local.bibliographicCitation.lastpage1097
local.bibliographicCitation.startpage1090
local.contributor.affiliationHodgson, Russell, University of Melbourne and Austin Health
local.contributor.affiliationChristiansen, Dale, Austin Health and University of Melbourne
local.contributor.affiliationZiolkowski, Andrew, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationMouhtouris, Effie, University of Melbourne and Austin Health
local.contributor.affiliationSimeonovic, Charmaine, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationIerino, Francesco, Austin Research Institute
local.contributor.affiliationSandrin, Mauro, Austin Research Institute
local.contributor.authoruidZiolkowski, Andrew, u3292935
local.contributor.authoruidSimeonovic, Charmaine, u8205698
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor110708 - Transplantation Immunology
local.identifier.absseo920108 - Immune System and Allergy
local.identifier.ariespublicationf2965xPUB1881
local.identifier.citationvolume91
local.identifier.doi10.1097/TP.0b013e31821774e0
local.identifier.scopusID2-s2.0-79955591494
local.identifier.thomsonID000290208500009
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Hodgson_Prolonged_Xenograft_Survival_2011.pdf
Size:
765.49 KB
Format:
Adobe Portable Document Format